✦ LIBER ✦

Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: A randomized phase 2 study

✍ Scribed by Infante, Jeffrey R.; Reid, Tony R.; Cohn, Allen L.; Edenfield, William J.; Cescon, Terrence P.; Hamm, John T.; Malik, Imtiaz A.; Rado, Thomas A.; McGee, Philip J.; Richards, Donald A.; Tarazi, Jamal; Rosbrook, Brad; Kim, Sinil; Cartwright, Thomas H.

Book ID: 120936070
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 330 KB
Volume: 119
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.28112

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Axitinib or Bevacizumab Plus FOLFIRI or

Axitinib or Bevacizumab Plus FOLFIRI or Modified FOLFOX-6 After Failure of First-Line Therapy for Metastatic Colorectal Cancer: A Randomized Phase II Study

✍ Bendell, Johanna C.; Tournigand, Christophe; Swieboda-Sadlej, Anna; Barone, Carl 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 292 KB

Phase II study of FOLFOX, bevacizumab an

Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer

✍ Meyerhardt, J.; Stuart, K.; Fuchs, C.; Zhu, A.; Earle, C.; Bhargava, P.; Blaszko 📂 Article 📅 2007 🏛 Oxford University Press 🌐 English ⚖ 84 KB

A multicenter phase II study of the stop

A multicenter phase II study of the stop-and-go modified FOLFOX6 with bevacizumab for first-line treatment of patients with metastatic colorectal cancer

✍ Natsuko T. Okita, Taito Esaki, Eishi Baba, Daisuke Sakai, Shinya Tokunaga, Hiroy 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 174 KB

Bevacizumab in Combination With Oxalipla

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

✍ Saltz, L. B.; Clarke, S.; Diaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 157 KB

FOLFOX4 With Cetuximab vs. UFOX With Cet

FOLFOX4 With Cetuximab vs. UFOX With Cetuximab as First-Line Therapy in Metastatic Colorectal Cancer: The Randomized Phase II FUTURE Study

✍ Douillard, Jean-Yves; Zemelka, Tomasz; Fountzilas, George; Barone, Carlo; Schlic 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 454 KB

Phase III Trial of FOLFOX plus Bevacizum

Phase III Trial of FOLFOX plus Bevacizumab or Cediranib (AZD2171) as First-Line Treatment of Patients with Metastatic Colorectal Cancer: HORIZON III

✍ Jane D. Robertson; Nick A. Botwood; Mace L. Rothenberg; Hans-Joachim Schmoll 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 77 KB